Jump to navigation
MSF calls on the stakeholders of the Global Fund to convene an emergency donor conference and to open a new early funding window to ensure that the Fund is fully functional in 2012.
Learn how a free trade agreement between the European Union and India could restrict access to affordable medicines for millions of people with HIV/AIDS and other diseases and conditions.
The crucial role India plays in supplying the developing world with affordable quality medicines is being threatened.
In the past 5 years, considerable progress has been made in scaling-up access to antiretroviral therapy. Today, 1.3 million people are receiving treatment. But a huge amount remains to be done.
Doctors Without Borders/Médecins Sans Frontières (MSF) is alarmed at the lack of availability of a key antiretroviral to treat HIV/AIDS, Gilead Science's tenofovir disoproxil fumarate (TDF), marketed as Viread®.
333 7th Avenue, New York, NY 10001-5004
A 501(c)(3) tax-exempt organization. Federal Identification Number (EIN): 13-3433452.